News & Events

Key 2026 Market Insights: Coordination, Clarity & Growth Signals
Why the macro market is shifting toward integrated care and what it means for investors and providers. 1. V28 &

Meet Ursamin and other hot start-ups this week in Atlanta at the Keiretsu Forum Southeast Investor Conference
Hosted by Keiretsu Forum Mid-Atlantic, South-East, and Texas, in partnership with the Angel Capital Association and Georgia Tech, this two-day

Ursamin Welcomes Clinical Informatics Leader Jill Rushton Miller, MD, to Advisory Team
Ursamin announces the addition of Dr. Jill Rushton Miller, a clinical informatics leader, to its advisory team.

Ursamin Selected for Prestigious Vanderbilt Innovation Startup Practicum
Ursamin has earned a coveted spot in the Vanderbilt Startups Practicum, a program designed to propel promising healthcare companies forward.

In the News: Ursamin Pilots Soar
Ursamin’s successful pilot program validates our commitment to developing technology that streamlines workflows and reduces physician burnout.

Celebrating Women Innovators: Shannon Aylesworth as a Top 100 in HealthTech
Parity’s Top 100 Women in HealthTech list celebrates remarkable women, including Ursamin’s CEO Shannon Aylesworth, who are shaping the future of healthcare.

Ursamin Announces Formation of Advisory Board for Enhanced Care Coordination
Ursamin’s new Advisory Board is shaping the future of care coordination in primary care. Learn about its impact on patient outcomes.

Ursamin Joins 2024 Project Healthcare Cohort
Ursamin, a healthcare tech leader in chronic disease care coordination, is proud to join the 2024 Project Healthcare Cohort at the Nashville Entrepreneur Center (NEC).

Company Update: Ursamin is Live!
We are excited to announce that Ursamin, our innovative healthcare platform, has officially launched. Next week, we’ll begin actively promoting

Ursamin Selected for Fulcrum Venture Accelerator’s Fifth Cohort of Promising Young Companies
We are thrilled to announce that Ursamin has been selected as a part of Fulcrum Venture Accelerator’s fifth cohort of